Declaration of Competing Interest statements were not included in published version of the following articles that appeared in previous issues of Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Hence, the authors of the below articles were contacted after publication to request a Declaration of Interest statement:
-
1.
“Social isolation during Covid-19: Boon or bane to diabetes management” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 567–568] https://doi.org/10.1016/j.dsx.2020.04.046
-
2.
“Are dietary amino acids prospectively predicts changes in serum lipid profile?” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (3): 1837–1843] https://doi.org/10.1016/j.dsx.2019.04.013
-
3.
“Reverse quarantine and COVID-19” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 1323–1325] https://doi.org/10.1016/j.dsx.2020.07.029
-
4.
“Upregulation of SCUBE2 expression in dyslipidemic type 2 diabetes mellitus is associated with endothelin-1” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (5): 2869–2872] https://doi.org/10.1016/j.dsx.2019.07.058
-
5.
“Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 12 (5): 791–794] https://doi.org/10.1016/j.dsx.2018.04.004
-
6.
“Cardiovascular events in patients with over 10 years history of type 2 diabetes mellitus” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 13 (1): 68–72] https://doi.org/10.1016/j.dsx.2018.08.026
-
7.
“Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 489–496] https://doi.org/10.1016/j.dsx.2020.04.038
-
8.
“Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (5): 2923–2926] https://doi.org/10.1016/j.dsx.2019.07.054
-
9.
“New anthropometric indices in the definition of metabolic syndrome in pediatrics” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (3): 1779–1784] https://doi.org/10.1016/j.dsx.2019.03.032
-
10.
“Effect of oral vitamin D supplementation on glycemic control in patients with type 2 diabetes mellitus with coexisting hypovitaminosis D: A parallel group placebo controlled randomized controlled pilot study” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 12 (4): 509–512] https://doi.org/10.1016/j.dsx.2018.03.008
-
11.
“Mechanism of inflammatory response in associated comorbidities in COVID-19” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 597–600] https://doi.org/10.1016/j.dsx.2020.05.025
-
12.
“Added sugar: Nutritional knowledge and consumption pattern of a principal driver of obesity and diabetes among undergraduates in UAE” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (4): 2579–2584] https://doi.org/10.1016/j.dsx.2019.06.031
-
13.
“A comparison of body mass index and percent body fat as predictors of cardiovascular risk factors” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 13 (1): 570–575] https://doi.org/10.1016/j.dsx.2018.11.012
-
14.
“Relationship of leukocytes, platelet indices and adipocytokines in metabolic syndrome patients” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 13 (1): 874–880] https://doi.org/10.1016/j.dsx.2018.12.016
-
15.
“Leptin: Adiponectin ratio discriminated the risk of metabolic syndrome better than adiponectin and leptin in Southwest Nigeria” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019; 13 (3): 1845–1849] https://doi.org/10.1016/j.dsx.2019.04.008